Igene Biotechnology, Inc.
IGNE
Rank in Stocks
#34361
Igene Biotechnology, Inc. is dedicated to the discovery, development,... Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes β from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Share Price
$0.00001
Last synced: 2026-11-09
Market Cap
$15.65K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Igene Biotechnology, Inc. (IGNE)
Category
Basic Materials
Operating Margin for Igene Biotechnology, Inc. (IGNE)
Operating Margin as of November 2026 TTM: -27.03%
According to Igene Biotechnology, Inc.'s latest financial reports, its current operating margin (TTM) is -27.03%. At the end of 2009 the company had an operating margin of -27.03%.
Operating Margin history for Igene Biotechnology, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -27.03% | 0.00% |
| 2009 | -27.03% | -5.59% |
| 2008 | -28.63% | -375.02% |
| 2007 | 10.41% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2003 | -134.79% | 154.27% |
| 2002 | -53.01% | 35.30% |
| 2001 | -39.18% | -81.77% |
| 2000 | -214.89% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.69% | -100.54% |
CA
|
|
| 38.12% | -101.41% |
US
|
|
| 57.71% | -102.14% |
CN
|
|
| 50.98% | -101.89% |
CN
|
|
| 25.08% | -100.93% |
SA
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Igene Biotechnology, Inc.'s operating margin
What is Igene Biotechnology, Inc.'s operating margin?
Igene Biotechnology, Inc.'s operating margin is -27.03%, as of Nov 2026.
What was Igene Biotechnology, Inc.'s operating margin in 2009?
In 2009, Igene Biotechnology, Inc.'s operating margin was -27.03%, compared with -28.63% in 2008.
How has Igene Biotechnology, Inc.'s operating margin changed since 2006?
From 2006 to 2009, Igene Biotechnology, Inc.'s operating margin was highest in 2007 (10.41%) and lowest in 2008 (-28.63%).
How does Igene Biotechnology, Inc.'s operating margin compare with similar companies?
Igene Biotechnology, Inc.'s operating margin (-27.03%) is lower than that of all 5 similar companies listed above. The highest among them is Qinghai Salt Lake Industry Co.,Ltd, with 57.71%.